Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis
Sponsor: Instituto de Medicina Molecular João Lobo Antunes
This observational or N/A phase trial investigates Ankylosing Spondylitis and Bone Resorption and is currently completed. Instituto de Medicina Molecular João Lobo Antunes leads this study, which shows 13 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
-
Jun 2022 — Dec 2022 [monthly]
Completed
▶ Show 8 earlier versions
-
Dec 2021 — Jun 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jan 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Instituto de Medicina Molecular João Lobo Antunes
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .